Vimarsana
Biggest News Aggregation in the World

Page 41 - Platform Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Platform Technology Today - Breaking & Trending Today

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program - Vimarsana News

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program

/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program - Vimarsana News

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program

/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program - Vimarsana News

Hummingbird Bioscience and Synaffix Enter License Agreement to Develop a Next Generation Antibody Drug Conjugate (ADC) Program

Synaffix to provide Hummingbird Bioscience access to proprietary ADC technologies Synaffix to receive up to $150m in upfront and milestone payments plus royalties SAN FRANCISCO, HOUSTON and SINGAPORE, Jan. 4, 2023 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, and Hummingbird Bioscience (Hummingbird Bio), a data-driven precision biotherapeutics company using its Rational Antibody Discovery (RAD) platform to discover an...

Effecti-cal Provides Immediate Bone Support (Without the Unpleasant Side Effects) - Vimarsana News

Effecti-cal Provides Immediate Bone Support (Without the Unpleasant Side Effects)

/PRNewswire/ -- Sinoveda is an innovative health brand committed to bringing the strengths of Eastern and Western medicine together. The company has used its...

Sinoveda's Proflexa Is Revolutionizing Pain Management - Vimarsana News

Sinoveda's Proflexa Is Revolutionizing Pain Management

/PRNewswire/ -- Pain relief is a subject that everyone can relate to. It doesn't matter if they are a middle-aged man dealing with a golfer's elbow, a young...